VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
BCLI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
BCLIBrainstorm Cell Therapeutics Inc.
$0.90$10M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksBCLIQuarterly Financials

Brainstorm Cell Therapeutics Inc. (BCLI) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Brainstorm Cell Therapeutics Inc. (BCLI) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

BCLI Income Statement

Quarterly statement

BCLI Income Statement

Brainstorm Cell Therapeutics Inc. (BCLI) annual income statement — 24-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue00000000000343K00000000
Revenue Growth %--------100%------------
Cost of Goods Sold046K37K48K0052K53K59K64K64K66K65K0070K00070K
COGS % of Revenue-----------19.24%--------
Gross Profit0-46K-37K-48K00-52K-53K-59K-64K-64K277K-65K00-70K000-70K
Gross Margin %-----------80.76%--------
Gross Profit Growth %--28.85%9.43%100%100%18.75%-119.13%9.23%--495.71%---0%100%---
Operating Expenses03.57M2.01M2.2M2.05M2.57M3.09M3.19M3.05M2.98M2.47M4.74M6.04M5.45M5.15M4.92M6.84M7.59M5.47M6.21M
OpEx % of Revenue-----------1381.34%--------
Selling, General & Admin02.65M1.28M-4.39M1.15M1.45M1.78M1.47M2M2.06M1.51M3.11M2.71M2.65M2.23M2.46M3.06M2.48M2.86M2.54M
SG&A % of Revenue-----------905.54%--------
Research & Development0917K725K-3.32M899K1.12M1.3M1.72M1.04M922K897K1.7M3.33M2.79M2.92M2.45M3.78M5.11M2.62M3.68M
R&D % of Revenue-----------495.04%--------
Other Operating Expenses0001000K00000064K-66K00000000
Operating Income0-3.61M-2.05M-2.24M-2.05M-2.57M-3.09M-3.19M-3.05M-2.98M-2.47M-4.8M-6.04M-5.45M-5.15M-4.92M-6.84M-7.59M-5.47M-6.21M
Operating Margin %------------1400.58%--------
Operating Income Growth %100%-40.42%33.77%29.63%32.84%13.72%-24.86%33.62%49.49%45.27%51.97%2.26%11.78%28.22%5.92%20.88%-29.64%-24.02%20.98%45.94%
EBITDA0-3.57M-2.01M-2.2M-2M-2.52M-3.04M-3.14M-2.99M-2.92M-2.41M-4.74M-5.97M-5.38M-5.08M-4.84M-6.77M-7.52M-5.4M-6.14M
EBITDA Margin %------------1381.34%--------
EBITDA Growth %100%-41.44%33.85%29.97%33.12%13.57%-26.02%33.81%49.93%45.78%52.6%2.21%11.83%28.43%5.87%21.12%-29.96%-24.11%21.36%46.25%
D&A (Non-Cash Add-back)046K37K48K48K51K52K53K59K64K64K66K65K67K67K70K70K71K74K70K
EBIT0-3.61M-2.05M-2.24M-2.05M-2.57M-3.09M-3.19M-3.05M-2.98M-2.47M-5.58M-6.04M-5.45M-5.15M-4.92M-6.84M-7.59M-5.47M-6.21M
Net Interest Income0-242K-81K284K-59K-330K46K-66K-54K30K13K-184.12K-121K120K92K-103K-17K550K115K22K
Interest Income000-46K0046K0030K13K-92.12K0120K92K00550K115K22K
Interest Expense199K242K81K-330K0330K066K54K0092K121K00103K17K000
Other Income/Expense0-242K-81K-190K-59K-330K225K216K340K441K-927K-774K4.81M120K92K-103K-17K550K115K22K
Pretax Income-1.73M-3.85M-2.13M-2.43M-2.11M-2.9M-2.86M-2.97M-2.71M-2.54M-3.4M-5.58M-1.23M-5.33M-5.06M-5.02M-6.86M-7.04M-5.36M-6.19M
Pretax Margin %------------1626.24%--------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-1.73M-3.85M-2.13M-2.43M-2.11M-2.9M-2.86M-2.97M-2.71M-2.54M-3.4M-5.58M-1.23M-5.33M-5.06M-5.02M-6.86M-7.04M-5.36M-6.19M
Net Margin %------------1626.24%--------
Net Income Growth %17.71%-32.79%25.73%18.13%22.23%-14.25%15.79%46.7%-120.88%52.32%32.77%-11.16%82.12%24.31%5.62%18.93%-28.52%-12.31%19.54%47.61%
Net Income (Continuing)0-3.85M-2.13M-2.43M-2.11M-2.9M-2.86M-2.97M-2.71M-2.54M-3.4M-5.58M-1.23M-5.33M-5.06M-5.02M-6.86M-7.04M-5.36M-6.19M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)0.00-0.35-0.19-0.22-0.19-0.34-0.45-0.52-0.51-0.54-0.79-1.66-0.42-1.95-2.10-0.14-2.85-2.85-2.25-0.17
EPS Growth %100%-2.94%57.78%57.69%62.75%37.04%43.04%68.67%-21.43%72.31%62.38%-1085.71%85.26%31.58%6.67%17.65%-26.67%-11.76%21.05%48.48%
EPS (Basic)0.00-0.35-0.19-0.22-0.19-0.34-0.45-0.52-0.51-0.54-0.79-1.66-0.42-1.95-0.13-0.14-2.85-2.85-2.25-0.17
Diluted Shares Outstanding011.03M11.03M9.27M11.01M8.62M6.34M5.71M5.31M4.75M4.32M3.36M2.95M2.65M2.45M2.44M2.43M2.43M2.43M2.42M
Basic Shares Outstanding011.03M11.03M9.27M11.01M8.62M6.34M5.71M5.31M4.75M4.32M3.36M2.95M2.65M2.45M2.44M2.43M2.43M2.43M2.42M
Dividend Payout Ratio--------------------